Cargando…

Patients' knowledge and perception on optic neuritis management before and after an information session

BACKGROUND: Patients' understanding of their condition affect the choice of treatment. The aim of this study is to evaluate patients' understanding and treatment preferences before and after an information session on the treatment of acute optic neuritis. METHODS: Participants were asked t...

Descripción completa

Detalles Bibliográficos
Autores principales: Matti, Albert I, Keane, Miriam C, McCarl, Helen, Klaer, Pamela, Chen, Celia S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854102/
https://www.ncbi.nlm.nih.gov/pubmed/20302669
http://dx.doi.org/10.1186/1471-2415-10-7
_version_ 1782180072837349376
author Matti, Albert I
Keane, Miriam C
McCarl, Helen
Klaer, Pamela
Chen, Celia S
author_facet Matti, Albert I
Keane, Miriam C
McCarl, Helen
Klaer, Pamela
Chen, Celia S
author_sort Matti, Albert I
collection PubMed
description BACKGROUND: Patients' understanding of their condition affect the choice of treatment. The aim of this study is to evaluate patients' understanding and treatment preferences before and after an information session on the treatment of acute optic neuritis. METHODS: Participants were asked to complete a questionnaire consisting of 14 questions before and after an information session presented by a neuro-ophthalmologist. The information session highlighted the treatment options and the treatment effects based on the Optic Neuritis Treatment Trial in plain patient language. The information session stressed the finding that high dose intravenous steroid therapy accelerated visual recovery but does not change final vision and that treatment with oral prednisone alone resulted in a higher incidence of recurrent optic neuritis. RESULTS: Before the information session, 23 (85%) participants knew that there was treatment available for ON and this increased to 27 (100%) after the information session. There were no significantly change in patients knowledge of symptoms of ON and purpose of treatment before and after the information session. Before the information session, 4 (14%) respondents reported they would like to be treated by oral steroid alone in the event of an optic neuritis and 5 (19%) did not respond. After the education session, only 1 patient (4%) indicated they would undergo treatment with oral steroid alone but 25 (92%) indicated they would undergo treatment with intravenous steroid treatment, alone or in combination with oral treatment. Results indicated that there were significant differences in the numbers of participants selecting that they would undergo treatment with a steroid injection (n = 22, p = 0.016). CONCLUSIONS: In this study, patients have shown good understanding of the symptoms and signs of optic neuritis. The finding that significant increases in the likelihood of patients engaging in best practice can be achieved with an information session is very important. This suggests that patient knowledge of available treatments and outcomes can play an important role in implementing and adopting guideline recommendations.
format Text
id pubmed-2854102
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28541022010-04-14 Patients' knowledge and perception on optic neuritis management before and after an information session Matti, Albert I Keane, Miriam C McCarl, Helen Klaer, Pamela Chen, Celia S BMC Ophthalmol Research article BACKGROUND: Patients' understanding of their condition affect the choice of treatment. The aim of this study is to evaluate patients' understanding and treatment preferences before and after an information session on the treatment of acute optic neuritis. METHODS: Participants were asked to complete a questionnaire consisting of 14 questions before and after an information session presented by a neuro-ophthalmologist. The information session highlighted the treatment options and the treatment effects based on the Optic Neuritis Treatment Trial in plain patient language. The information session stressed the finding that high dose intravenous steroid therapy accelerated visual recovery but does not change final vision and that treatment with oral prednisone alone resulted in a higher incidence of recurrent optic neuritis. RESULTS: Before the information session, 23 (85%) participants knew that there was treatment available for ON and this increased to 27 (100%) after the information session. There were no significantly change in patients knowledge of symptoms of ON and purpose of treatment before and after the information session. Before the information session, 4 (14%) respondents reported they would like to be treated by oral steroid alone in the event of an optic neuritis and 5 (19%) did not respond. After the education session, only 1 patient (4%) indicated they would undergo treatment with oral steroid alone but 25 (92%) indicated they would undergo treatment with intravenous steroid treatment, alone or in combination with oral treatment. Results indicated that there were significant differences in the numbers of participants selecting that they would undergo treatment with a steroid injection (n = 22, p = 0.016). CONCLUSIONS: In this study, patients have shown good understanding of the symptoms and signs of optic neuritis. The finding that significant increases in the likelihood of patients engaging in best practice can be achieved with an information session is very important. This suggests that patient knowledge of available treatments and outcomes can play an important role in implementing and adopting guideline recommendations. BioMed Central 2010-03-21 /pmc/articles/PMC2854102/ /pubmed/20302669 http://dx.doi.org/10.1186/1471-2415-10-7 Text en Copyright ©2010 Matti et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Matti, Albert I
Keane, Miriam C
McCarl, Helen
Klaer, Pamela
Chen, Celia S
Patients' knowledge and perception on optic neuritis management before and after an information session
title Patients' knowledge and perception on optic neuritis management before and after an information session
title_full Patients' knowledge and perception on optic neuritis management before and after an information session
title_fullStr Patients' knowledge and perception on optic neuritis management before and after an information session
title_full_unstemmed Patients' knowledge and perception on optic neuritis management before and after an information session
title_short Patients' knowledge and perception on optic neuritis management before and after an information session
title_sort patients' knowledge and perception on optic neuritis management before and after an information session
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854102/
https://www.ncbi.nlm.nih.gov/pubmed/20302669
http://dx.doi.org/10.1186/1471-2415-10-7
work_keys_str_mv AT mattialberti patientsknowledgeandperceptiononopticneuritismanagementbeforeandafteraninformationsession
AT keanemiriamc patientsknowledgeandperceptiononopticneuritismanagementbeforeandafteraninformationsession
AT mccarlhelen patientsknowledgeandperceptiononopticneuritismanagementbeforeandafteraninformationsession
AT klaerpamela patientsknowledgeandperceptiononopticneuritismanagementbeforeandafteraninformationsession
AT chencelias patientsknowledgeandperceptiononopticneuritismanagementbeforeandafteraninformationsession